GE Healthcare Technologies Inc. is participating in the €25.3 million (US$27.8 million) Thera4care project that aims to ...

Astrazeneca plc is adding a preclinical-stage candidate to its cardiovascular pipeline via a potentially $2 billion licensing agreement with CSPC Pharmaceutical Group Ltd., which includes a $100 ...

WAYNE, Pa. and ORMOND BEACH, Fla., Oct. 8, 2024 /PRNewswire/ -- Command Medical Products ("CMP" or the "Company") is pleased to announce that Karen West has joined its Board of ...

We recently compiled a list titled 7 Best Cheap Stocks to Buy According to Billionaire Ray Dalio. In this article, we will ...

Johnson & Johnson discontinues the Phase 3 SunRISe-2 trial for TAR-200 in bladder cancer, citing lack of superiority. Q3 ...

Investing.com -- Oppenheimer initiated coverage of Abbott Laboratories (NYSE: ABT) with an Outperform rating and a price ...

The agency will consider national reimbursement for new tricuspid transcatheter repair devices, including Abbott’s Triclip, in Medicare patients with a leaky tricuspid heart valve.

Johnson & Johnson MedTech today announced that it filed an FDA 510(k) submission for the latest Monarch platform software ...

Medtronic has been notifying users of its MiniMed insulin pumps to be aware of potentially shortened battery lives, and to ...

On the non-MedTech side, Nutrition and Diagnostics sales comps will ease over the next few years, driving revenue growth with ...

SymPhysis Medical raised $2.4 million (€2.2 million) to support its Releaze drainage system for cancer patients, RTE reports.

Johnson & Johnson (JNJ – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...